Showing results (111-120 of 162) with videos related to
Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|June 28, 2024
Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutationsAnna Kron, Matthias Scheffler, Marcel Wiesweg, et al.BMC Medical Genomics|February 28, 2021
Detection of gene fusions using targeted next-generation sequencing: a comparative evaluationCarina Heydt, Christina B Wölwer, Oscar Velazquez Camacho, et al.Lung Cancer (Amsterdam, Netherlands)|August 14, 2023
Clinicopathologic and molecular characteristics of small-scale ROS1-mutant non-small cell lung cancer (NSCLC) patientsMoritz Glaser, Anna Rasokat, Darinka Prang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2026
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS Q61 mutations to assess therapeutic responsesLea Ruge, Felix John, Malte Verheyen, et al.Gut|May 24, 2015
Activating ERBB2/HER2 mutations indicate susceptibility to pan-HER inhibitors in Lynch and Lynch-like colorectal cancerMichael Kloth, Vanessa Ruesseler, Christoph Engel, et al.Journal of Cancer Research and Clinical Oncology|July 14, 2023
Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerFabinshy Thangarajah, Jana Busshoff, Janina Salamon, et al.Virchows Archiv : an International Journal of Pathology|June 26, 2021
Status quo of ALK testing in lung cancer: results of an EQA scheme based on in-situ hybridization, immunohistochemistry, and RNA/DNA sequencingPhilipp Jurmeister, Claudia Vollbrecht, Korinna Jöhrens, et al.Genes, Chromosomes & Cancer|April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assaysMartina Kirchner, Julia Glade, Ulrich Lehmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Clinical and Pathological Characteristics of <i>KEAP1</i>- and <i>NFE2L2</i>-Mutated Non-Small Cell Lung Carcinoma (NSCLC)Rieke Frank, Matthias Scheffler, Sabine Merkelbach-Bruse, et al.Lung Cancer (Amsterdam, Netherlands)|April 23, 2022
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implicationsMatthias Scheffler, Marcel Wiesweg, Sebastian Michels, et al.Pageof 17